Clark Estates Inc’s GSK GSK Stock Holding History

Clark Estates Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-260,000	Closed	-$14.1M	–	91
2022 Q2	$14.1M	Hold	260,000	–	–	2.45%	11
2022 Q1	$14.2M	Sell	260,000 -100,000	-28%	-$5.43M	2.23%	13
2021 Q4	$19.8M	Sell	360,000 -68,000	-16%	-$3.54M	2.9%	8
2021 Q3	$20.4M	Hold	428,000	–	–	2.92%	7
2021 Q2	$21.3M	Hold	428,000	–	–	2.78%	8
2021 Q1	$19.1M	Buy	428,000 +40,000	+10%	+$1.82M	2.44%	9
2020 Q4	$17.8M	Buy	388,000 +120,000	+45%	+$5.51M	2.52%	7
2020 Q3	$12.6M	Buy	268,000 +80,000	+43%	+$4.01M	2.06%	14
2020 Q2	$9.59M	Hold	188,000	–	–	1.68%	18
2020 Q1	$8.9M	Buy	188,000 +120,000	+176%	+$6.4M	1.81%	12
2019 Q4	$3.99M	Sell	68,000 -120,000	-64%	-$6.67M	0.61%	45
2019 Q3	$10M	Hold	188,000	–	–	1.65%	17
2019 Q2	$9.4M	Hold	188,000	–	–	1.5%	18
2019 Q1	$9.82M	Sell	188,000 -68,000	-27%	-$3.4M	1.52%	18
2018 Q4	$12.2M	Sell	256,000 -64,000	-20%	-$3.15M	1.96%	15
2018 Q3	$16.1M	Sell	320,000 -40,000	-11%	-$2.03M	2.41%	13
2018 Q2	$18.1M	Sell	360,000 -120,000	-25%	-$6.04M	2.71%	13
2018 Q1	$23.4M	Sell	480,000 -40,000	-8%	-$1.86M	3.75%	8
2017 Q4	$23.1M	Buy	520,000 +308,000	+145%	+$14.2M	3.81%	7
2017 Q3	$10.8M	Buy	+212,000	New	+$10.8M	1.79%	14
2017 Q2	–	Sell	-60,000	Closed	-$3.16M	–	90
2017 Q1	$3.16M	Buy	+60,000	New	+$3.04M	0.49%	50

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Clark Estates Inc's GSK Position: Q3 2022 in Review

Clark Estates Inc sold out of GSK (GSK) in Q3 2022, closing a stake of 260,000 shares — an estimated $14.1M sold.

Clark Estates Inc first reported a position in GSK in Q1 2017 and held it in 21 quarters. The position peaked at $23.4M in Q1 2018. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Clark Estates Inc reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Clark Estates Inc sold 260,000 GSK shares in Q3 2022, an estimated $14.1M.
Clark Estates Inc first reported a position in GSK in Q1 2017 and held it in 21 quarters.
Clark Estates Inc's GSK position peaked at $23.4M in Q1 2018.
743 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Clark Estates Inc's 13F filing for Q3 2022, filed 14 Nov 2022.